Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Immunoprecise Antibodies Ltd

(TSX-V: IPA.VN)
Add to Portfolio
-0.030 (-4.84%)
as of Sep 20, 2019

Last 0.590
Change -0.030 (-4.84%)
Open 0.630
Prev. Close 0.620
Today's Range
0.590
0.630
52wk Range
0.500
0.980
Volume 87,559
Avg Volume 73,884

Perfomance Comparison

Name Today 3-Month 1-Year
IPA.VN -4.84% -14.49% -40.40%
$TXCX +0.25% +2.03% +4.22%
$TXSC +0.19% +2.07% +5.23%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -0.120
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 40,084
Weighted Alpha -37.50
Standard Deviation -0.88
Profit Margin -0.70%
Beta 3.986

Growth Rates

YTD -16.90%
1-Year -39.18%
3-Year +555.56%

Opinion

Sell Hold Buy

Recent Headlines

ImmunoPrecise Antibodies' Annual Revenues Increase

CNW Group via COMTEX - Wed Aug 28, 06:33PM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF) today reports its financial results for the year ended April 30, 2019. The financial statements and related Management's Discussion and A(full story)
IPATF: 0.4518 (-0.0177), IPA.VN: 0.590 (-0.030)

ImmunoPrecise's Wholly Owned Talem Therapeutics

CNW Group via COMTEX - Thu Aug 01, 08:00AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB PINK: IPATF) announces the launch of its High Value Target Scientific Committee which will strengthen the scientific oversight and methodological pra(full story)
IPATF: 0.4518 (-0.0177), IPA.VN: 0.590 (-0.030)

ImmunoPrecise Antibodies Announces Immuno-oncology

CNW Group via COMTEX - Mon Jul 15, 08:30AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), an industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that it has entered into a new antibody discov(full story)
IPATF: 0.4518 (-0.0177), IPA.VN: 0.590 (-0.030)

ImmunoPrecise Guarantees Success for Customers of

CNW Group via COMTEX - Wed Jun 26, 08:15AM EDT
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), the industry leader in the discovery of novel, therapeutic monoclonal antibodies, announces that from this point forward it will guarante(full story)
IPATF: 0.4518 (-0.0177), IPA.VN: 0.590 (-0.030)

ImmunoPrecise Antibodies Announces an Unprecedented

CNW Group via COMTEX - Thu May 30, 08:30AM EDT
The Diversified Offerings of 9 Transgenic Animal Strains Platforms supports Solid Growth in Drug Discovery Services(full story)
IPATF: 0.4518 (-0.0177), IPA.VN: 0.590 (-0.030)